EquityFlow
›
Companies
› Biomatter
Biomatter
biotech
· Vilnius, LT
Generative AI platform for designing novel enzymes.
Funding history
Date
Round
Amount
Aug 2024
Seed
Biomatter closed a €6.5M seed round led by Inventure and UVC Partners to advance its AI enzyme design platform.
$6.8M
Investors
Inventure
Practica Capital
UVC Partners
Similar companies in biotech
Antag Therapeutics
Adcendo
Freya Biosciences
TXN Systems
Promise Bio
Concinnity Genetics
Noema Pharma
MabGenesis
RadioNano Therapeutics
Citryll
Alveron Pharma
AQEMIA
Explore funding flow on EquityFlow →